DESCRIPTIONPERSONNELINTERNSHIPSSERVICESPUBLICATIONSRESOURCES

Mission

The purpose of the CFAR Biostatistics Core is to accelerate successful HIV/AIDS research by direct provision of biostatistical support and by arranging mutually beneficial collaborations between CFAR researchers and statistical scientists.

We provide biostatistical support that is readily available to CFAR investigators and to other CFAR Cores. In addition to making strategic contributions to the CFAR’s scientific dialog, we provide statistical consulting services that range from brief professional consultations to invention of new statistical methods. We collaborate on the framing of hypotheses and on the development of study designs, grant applications, journal articles and presentations, selection of statistical methods, performance of statistical computations and interpretive analyses, and research database management consultation and support.

The Biostatistics Core brings together CFAR investigators and professional biostatisticians who possess specialized expertise needed for CFAR research projects. We promote opportunities for faculty and students in the statistical sciences at UNC to participate in HIV/AIDS-related research and become members of the CFAR. The participating faculty of the Biostatistics Department forms an important component of the Biostatistics Core.

We also promote training opportunities for CFAR investigators who are interested in the application of best statistical methods, and provide training opportunities for students and fellows who are assisting in AIDS-related studies. We recommend that investigators contact the Biostatistics Core in the earliest stage of new research efforts and well in advance of deadlines for grant applications, abstract submissions and protocol development.

Please contact the CFAR Biostatistics Core with new requests by e-mailing us at CFARbios@bios.unc.edu.

Specific Aims

The goal of the Biostatistics Core is to support and enhance AIDS research of the UNC CFAR. We will accomplish these goals with the following Aims:

Aim 1: Provide a broad spectrum of collaborative biostatistical services

Aim 2: Develop, implement, and disseminate innovative statistical methods for HIV/AIDS research

Aim 3: Support priority CFAR initiatives and goals

Aim 4: Promote CFAR research within UNC, foster inter-CFAR collaborations, and support HIV/AIDS research networks

Aim 5: Provide biostatistical training, mentoring, and education

Aim 6: Engage in evaluation and strategic planning

By accomplishing these Aims the Biostatistics Core will continue to provide key statistical support for the UNC CFAR, ensuring sound statistical design, conduct, and analysis of research leading to a deeper understanding of the HIV epidemic.

Michael Hudgens, Ph.D.

Core Director

Michael Hudgens

 

Dr. Michael Hudgens is a Professor in the Department of Biostatistics at UNC-Chapel Hill and is Director of the Biostatistics Core of the UNC Center for AIDS Research. He has experience in collaborative research and statistical methodology development related to studies of infectious diseases, with emphasis on HIV. Professor Hudgens has co-authored more than 200 peer-reviewed papers in statistical journals such as Biometrics, Biometrika, JASA and JRSS-B as well as biomedical journals such as the Lancet, Nature and New England Journal of Medicine. He currently serves as an Associate Editor for Biometrics, JASA and JRSS-B. He is an elected Fellow of the American Statistical Association and has taught graduate level biostatistics courses at UNC for over ten years.

3107C McGavran-Greenberg
Chapel Hill, NC
mhudgens@bios.unc.edu
Office Phone: 919-966-7253

 

Stephen R Cole, Ph.D.

Associate Core Director

Stephen Cole
Dr. Cole is a Professor of Epidemiology at UNC with an interest in quantitative epidemiologic methods. He is Associate Director of the Biostatistics Core of the UNC Center for AIDS Research, as well as Director of the Epidemiology and Biostatistics Core of the CFAR Network of Integrated Clinical Systems (CNICS). His research focuses on the use of structural models to explore the causal effect of antiretroviral therapies on HIV disease progression, and direct and indirect causal effects of alcohol intake on HIV acquisition. He is also a member of a Causal Inference Research Group (CIRG) at UNC.

 

2105E McGavran-Greenberg Hall
Chapel Hill, NC
cole@unc.edu
Office Phone: 919-966-7415

 

Katie Mollan, M.S.

Core Manager / Senior Biostatistician

Katie Mollan

 

Katie Mollan, MS, is a Senior Biostatistician and Core Manager at the UNC Center for AIDS Research within the School of Medicine. She has considerable experience in HIV research since 2006, with an emphasis on statistical design and analysis of domestic and international clinical trials. Ms. Mollan has provided statistical support for numerous grant proposals and HIV/AIDS studies, including for the AIDS Clinical Trials Group (ACTG), the HIV Prevention Trials Network (HPTN), and investigator-initiated HIV studies conducted at UNC. Ms. Mollan has co-authored over 45 peer-reviewed articles pertaining to HIV/AIDS, in journals including Annals of Internal Medicine, The Lancet, Journal of Infectious Diseases, Clinical Infectious Diseases, and the New England Journal of Medicine. Her collaborative research background spans a breadth of topics including HIV testing, mental health comorbidities, antiretroviral efficacy, pharmacokinetics, drug resistance, adherence, participant-reported outcomes, vaccine development, and HIV cure. Her research interests include HIV and mental health epidemiology, applied causal inference, and statistical power.

3126 McGavran-Greenberg Hall
Chapel Hill, NC
kmollan@email.unc.edu
Office Phone: 919-966-8421

 

Fei Zou, Ph.D.

Participating Faculty

Dr. Fei Zou
Dr. Zou is a Professor in the Department of Biostatistics and the Department of Genetics at the University of North Carolina at Chapel Hill. Her research interest is in the development of theoretical methodologies appropriate for interpretation of high-dimensional genetics and genomics data. She is highly experienced in gene expression data analysis, genome wide association (GWA) mapping, and next generation sequencing data analysis. She is also experienced in designing clinical trials, and analysis of complex observational data.

 

4115D McGavran-Greenberg Hall
Chapel Hill, NC
feizou@email.unc.edu
Office Phone: 919-843-4822

Pooja Saha, B.S.P.H.

Research Assistant

Pooja Saha
Pooja Saha is a Ph.D. candidate in the biostatistics department at UNC. She received her B.S.P.H in Biostatistics and B.S. in Mathematics from UNC Chapel Hill as well. Prior to joining CFAR, she worked for UNC School of Dentistry as a graduate research assistant providing statistical support to faculty members and students.

 

 

 

Bonnie Shook-Sa, M.A.S.

Research Assistant

Bonnie Shook-Sa
Bonnie Shook-Sa is a DrPH student in the Biostatistics Department at UNC Chapel Hill.  She received a B.S. in Mathematics and a B.A. in Political Science from Marshall University and a M.A.S. in Applied Statistics from Ohio State University.  Before coming to UNC, Bonnie worked as a Senior Research Statistician at RTI International, where her research focused on sample design, development of sampling weights, and the analysis of complex survey data.

 

 

Ann Marie Weideman, M.S.

Research Assistant

Ann Marie Weideman
Ann Marie Weideman is a PhD student in the Biostatistics Department at UNC. She received a B.S. and M.S. in Mathematics from University of Maryland, Baltimore County. Before joining the CFAR, she worked as a post-baccalaureate fellow at the National Institutes of Health (NIH), where her research focused on developing mathematical and statistical models to predict disease progression in patients with multiple sclerosis. During her fellowship at the NIH, she worked as adjunct faculty at Capitol Technology University, where she taught engineering statistics and differential equations. Ann Marie has interests in high performance computing, web-app design, and watercolor painting.

 

Matt Gilleskie, B.S.P.H.

Data Analyst

Matt graduated from UNC with a BSPH in Biostatistics in 2019. He then joined the Center for AIDS Research full-time. He assists the Clinical Core with data management, clinical screening, and web application support. His work with the Biostatistics Core primarily consists of data management, data visualization, and providing support for HIV/AIDS research projects. Matt is working to advance the research he conducted for his senior honors thesis, which investigated the spatial relationships between community-level health determinants and the well-being of HIV+ patients in the UNC Infectious Disease Clinic.

 
 
 

Past Students (2012 Onward)

Former Biostatistics Graduate Research Assistants [updates circa 2019]

  • Sarah Reifeis, B.S. [Doctoral Research, UNC]
  • Ilana Trumble, M.S. [Doctoral Research, UC DENVER]
  • Andrew G. Allmon, B.S. [Doctoral Research, United Therapeutics, UCB]
  • Pedro Baldoni, M.S. [Doctoral Research & Hispanic Community Health Study]
  • Owen Francis, M.S. [Doctoral Research]
  • Brian Barkley, Ph.D [Biostatistical Consultant, Medical College of Wisconsin]
  • Joseph Rigdon, Ph.D. [Stanford Med/Quant Sciences Unit]
  • Lu Mao, Ph.D. [University of Wisconsin Madison]
  • Amy Richardson, Ph.D. [Google]

UNC CFAR Biostatistics Summer Internship

Download the PDF

Past CFAR Summer Interns

 

 

 

 

HarLeigh Haynie (2019) [Winston-Salem State University]

 

 

 

 

 

Emma Crenshaw (2018) [UNC Class of 2019]

 

 

 

 

Jake Mathura (2018)

 

 

 

 

 

Orlando Ferrer, B.S. (2017) [Doctoral Student, Wake Forest]

 

 

 

 

 

Sumati Sridhar (2017) [UNC Class of 2019]

The UNC CFAR Biostatistics Core offers a range of services to CFAR investigators, including:

• Study Design and Planning
• Grant Proposal Support
• Statistical Computation, Derivation, Interpretive Analysis and Publication
• Data Carpentry and Visualizations
• Statistical Methods Research and Development
• Database Consultation
• Training and Tutorial Consultation
• Mentoring
• Referrals

Publications

2019

Archin NM, Kirchherr JL, Sung JA, Clutton G, Sholtis K, Xu Y, Allard B, Stuelke E, Kashuba AD, Kuruc JD, Eron J, Gay CL, Goonetilleke N, Margolis DM (2017). Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency. J Clin Invest;127(8):3126-3135. PMID: 28714868 PMCID: PMC5531421

Billock RM, Samoff E, Cope AB, Sampson LA, Hurt CB, Powers KA (2018). Repeat HIV testing by transmission risk group and rurality of residence in North Carolina. Sex Tran Dis;45(10):684-689. PMID: 29771865 PMCID: PMC6136956

Bradley T, Ferrari G, Haynes BF, Margolis DM, Browne EP (2018). Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency. Cell Rep;25(1):107-117.e3. PMID: 30282021 PMCID: PMC6258175

Bula A, Kopp DM, Maman S, Chinula L, Tsidya M, Tang JH (2018). Family planning knowledge, experiences and reproductive desires among women who had experienced a poor obstetric outcome in Lilongwe Malawi: a qualitative study. Contracept Reprod Med;3:22. PMID: 30349736 PMCID: PMC6192333

Chagomerana MB, Miller WC, Tang JH, Hoffman IF, Harrington BJ, DiPrete B, Wallie S, Jumbe A, Limarzi L, Hosseinipour MC (2018). Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi. PLoS One;13(12):e0209052. PMID: 30543685 PMCID: PMC6292583

Chinula L, Nelson JAE, Wiener J, Tang JH, Hurst S, Tegha G, Msika A, Ellington S, Hosseinipour MC, Mataya R, Haddad LB, Kourtis AP (2018). Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial. Contraception;98(3):193-98. PMID: 29746813 PMCID: PMC6143482 

Conserve DF, Alemu D, Yamanis T, Maman S, Kajula L (2018). “He Told Me to Check My Health”: A Qualitative Exploration of Social Network Influence on Men’s HIV Testing Behavior and HIV Self-Testing Willingness in Tanzania. Am J Mens Health;12(5):1185-1196. PMID: 29808781 PMCID: PMC6142152

Conserve DF, Muessig K, Maman S, Kajula S (2018). Mate Yako Afya Yako: Formative Research to Develop the Peer-Based HIV Self-Testing Education and Promotion (STEP) Intervention for Networks of Men in Tanzania. Plos One Journal;13(8):e0202521. PMID: 30148846 PMCID: PMC6110473

Costenbader E, Cislaghi B, Clark CJ, Hinson L, Lenzi R, McCarraher DR, McLarnon-Silk C, Pulerwitz J, Shaw B, Stefanik L (2019). Social Norms Measurement: Catching up with Programs and Moving the Field Forward. J Adol Health;64(4):S4-S6. PMID: 30914167 PMCID: PMC6426726

Davey DJ, Peters RPH, Kojima N, Mudau M, De Vos L, Olivier D, McIntyre JA, Klausner JD, Medina-Marino A (2018). Sexual behaviors of HIV-infected pregnant women and factors associated with sexual transmitted infection in South Africa. Sex Transm Dis;45(11):754-761. PMID: 29624560 PMCID: PMC6173658

Eley NT, Namey E, McKenna K, Johnson AC, Guest G (2019). Beyond the Individual: Social and Cultural Influences on the Health-Seeking Behaviors of African American Men. Am J Men’s Health;13(1):1-11. PMID: 30767594 PMCID: PMC6440067

Ewing AC, Davis NL, Kayira D, Hosseinipour MC, van der Horst C, Jamieson DJ, Kourtis AP; Breastfeeding, Antiretrovirals and Nutrition study team (2019). Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010. Emerg Infect Dis;25(1):103-112. PMID: 30561313 PMCID: PMC6302572

Fray NA, Caldwell KL (2017). Communication Between SES Black Women and Healthcare Providers About HIV Testing. J Natl Med Assoc;109(2):115-125. PMID: 28599753 PMCID: PMC6324584

Gausi B, Chagomerana MB, Tang JH, Hosseinipour MC, Haddad LB, Hannock T, Phiri S (2018). Human Immunodeficiency Virus Serodiscordance and Dual Contraceptive Method Use Among Human Immunodeficiency Virus-Infected Men and Women in Lilongwe, Malawi. Sex Transm Dis;45(11):747-753. PMID: 30303948 PMCID: PMC6200388

Herce ME, Miller WM, Bula A, Edwards JK, Sapalalo P, Lancaster KE, Mofolo I, Furtado MLM, Weir SS (2018). Achieving the first 90 for key populations in sub-Saharan Africa through venue-based outreach: challenges and opportunities for HIV prevention based on PLACE study findings from Malawi and Angola. J Int AIDS Soc;21(Suppl 5):e25132. PMID: 30033589 PMCID: PMC6055127

Hermes DJ, Xu C, Poklis JL, Niphakis MJ, Cravatt BF, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Fitting S (2018). Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. Neuropharmacology;141:55-65. PMID: 30114402 PMCID: PMC6296377

Kayongo A, Gonzalo-Gil E, Gümüşgöz E, Niwaha AJ, Semitala F, Kalyesubula R, Bagaya BS, Joloba ML, Sutton RE (2018). Brief Report: Identification of Elite and Viremic Controllers from a Large Urban HIV Ambulatory Center in Kampala, Uganda. J Acquir Immune Defic Syndr;79(3):394-398. PMID: 30063647 PMCID: PMC6186412

Ke R, Conway JM, Margolis DM, Perelson AS (2018). Determinants of the efficacy of HIV latency-reversing agents and implications for drug and treatment design. JCI Insight;3(20): e123052. PMID: 30333308 PMCID: PMC6237475

Kopp DM, Bula A, Maman S, Chinula L, Tsidya M, Mwale M, Tang JH (2018). Influences on birth spacing intentions and desired interventions among women who have experienced a poor obstetric outcome in Lilongwe Malawi: a qualitative study. BMC Pregnancy Childbirth;18(1):197. PMID: 29855296 PMCID: PMC5984328

Kovarova M, Benhabbour SR, Massud I, Spagnuolo RA, Skinner B, Baker CE, Sykes C, Mollan KR, Kashuba ADM, García-Lerma JG, Mumper RJ, Garcia JV (2018). Ultra-long-acting removable drug delivery system for HIV treatment and prevention. Nat Commun;9(1):4156. PMID: 30297889 PMCID: PMC6175887

Lancaster KE, Hetrick A, Jaquet A, Adedimeji A, Atwoli L, Colby DJ, Mayor AM, Parcesepe A, Syvertsen J (2018).  Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities. J Virus Erad;4(Suppl 2):26-32. PMID: 30515311 PMCID: PMC6248849

Masa R, Chowa G, and Nyirenda V (2017a). Prevalence and predictors of food insecurity among people living with HIV enrolled in antiretroviral therapy and livelihood programs in two rural Zambian hospitals. Ecology of Food and Nutrition;56(3):256-276. PMID: 28418728 PMCID: PMC5953554

Masa R, Chowa G, and Nyirenda V (2017b). Barriers and facilitators of antiretroviral therapy adherence in rural Eastern Province, Zambia: The role of household economic status. African Journal of AIDS Research;16(2):91-99. PMID: 28639469 PMCID: PMC5963730

Matoga M, Mmodzi P, Massa C, Bula A, Hosseinipour M, Chasela C (2018). Health System Factors Influencing Partner Notification for STIs and HIV in Lilongwe Malawi. A Pre-Intervention Phase Assessment for a Quality Improvement Project. J Infect Dis Med;3(1):125. PMID: 29707699 PMCID: PMC5918274

Miller WC, Lesko CR, Powers KA (2014). The HIV care cascade: simple concept, complex realization. Sex Transm Dis;41(1):41-2. PMID: 24326580 PMCID: PMC4084671

Ngongondo M, Miyahara S, Hughes MD, Sun X, Bisson GP, Gupta A, Kumwenda J, Lavenberg JA, Torres TS, Nyirenda M, Kidonge KK, Hosseinipour MC; AIDS Clinical Trials Group A5274 (REMEMBER) Study Team (2018).  Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living with HIV with Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial. J Acquir Immune Defic Syndr;78(1):54-61. PMID: 29406428 PMCID: PMC5889344

Ngongondo M, Rosenberg NE, Stanley CC, Lim R, Ongubo D, Broadhurst R, Speight C, Flick R, Tembo P, Hosseinpour MC (2018). Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study. BMC Infect Dis;18(1):39. PMID: 29334932 PMCID: PMC5769314

Nwaohiri AN, Tang JH, Stanczyk F, Chinula L, Hurst S, Davis NL, Tegha G, Haddad L, Kourtis AP (2018). Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolled in a randomized controlled trial. Contraception;97(4):354-6. PMID: 29246819. PMCID: PMC5840008

Sullivan KA, Little M, Rosenberg NE, Mtande T, Zimba C, Jaffe E, Anderson J, Coleman JS, Gilbert S, Gross Wolf MS, Hoffman I, Rahangdale L, Faden R, Lyerly AD (2018). Women’s Views About a Paternal Consent Requirement for Biomedical Research in Pregnancy. J Empir Res Hum Res Ethics;13(4):349-362. PMID: 29998787 PMCID: PMC6360530

Tang JH, Lemani C, Nkambule J, Talama G, Banda C, Zgambo W, Chagomerana M (2018). Two-year contraceptive continuation rates among immediate postpartum implant users at a district hospital in Malawi: a prospective cohort study. Contraception;98(3):220-222. PMID: 29750925 PMCID: PMC6143381

Torres TS, Harrison LJ, La Rosa AM, Lavenberg JA, Zheng L, Safren SA, Ngongondo M, Poongulali S, Matoga M, Samaneka W, Collier AC, Hughes MD (2018a). Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings. AIDS Care;30(8):954-962. PMID: 29343078 PMCID: PMC6100767

Torres TS, Harrison LJ, La Rosa AM, Cardoso SW, Zheng L, Ngongondo M, Some F, Lalloo UG, Mwelase T, Collier AC, Hughes MD; AIDS Clinical Trials Group (ACTG) A5273 Study Group (2018b). Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS;32(5):583-593. PMID: 29334547 PMCID: PMC5832593

Vogt SL, Moosa P, Omar T, Pather S, Martinson N, Ambinder RF (2017). Molecular diagnostics for AIDS lymphoma diagnosis in South Africa and the potential for other low-and middle-income countries. J Glob Oncol;4:1-6. PMID: 30241211 PMCID: PMC6180762

Wood D, Lancaster KE, Boily MC, Powers KA, Donnell D, Cohen MS, Dimitrov DT (2018). Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently? J Acquir Immune Defic Syndr;77(4):350-357. PMID: 29206720 PMCID: PMC5825250

Wu D, Tang W, Lu H, Zhang TP, Cao B, Ong JJ, Lee A, Liu C, Huang W, Fu R, Li K, Pan SW, Zhang Y, Fu H, Wei C, Tucker JD (2019). Leading by Example: Web-Based Sexual Health Influencers Among Men Who Have Sex With Men Have Higher HIV and Syphilis Testing Rates in China. J Med Internet Res;21(1):e10171. PMID: 30664490 PMCID: PMC6360381

Yotebieng M, Brazier E, Addison D, Kimmel AD, Cornell M, Keiser O, Parcesepe AM, Onovo A, Lancaster KE, Castelnuovo B, Murnane PM, Cohen CR, Vreeman RC, Davies MA, Duda SN, Yiannoutsos CT, Bono RS, Agler R, Bernard C, Syvertsen JL, Sinayobye JD, Wikramanayake R, Sohn AH, von Groote PM, Wandeler G, Leroy V, Williams CF, Wools-Kaloustian K, Nash D, IeDEA Treat All in sub-Saharan Africa Consensus Statement Working Group (2019). Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc;22(1):e25218. PMID: 30657644 PMCID: PMC6338103

2018

Adimora AA, Cole SR, Eron JJ. US Black Women and Human Immunodeficiency Virus Prevention: Time for New Approaches to Clinical Trials. Clin Infect Dis. 2017 Jul 15;65(2):324-327. PMID number: 28383649. PMC number: PMC5850546.

Belenky N, Pence BW, Cole SR, Dusetzina SB, Edmonds A, Oberlander J, Plankey MW, Adedimeji A, Wilson TE, Cohen J, Cohen MH, Milam JE, Golub ET, Adimora AA. Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV. Med Care. 2018 Jan;56(1):47-53. PMID number: 29227443. PMC number: PMC5728680.

Bengtson AM, Pence BW, Eaton EF, Edwards JK, Eron JJ, Mathews WC, Mollan K, MooreRD, O’Cleirigh C, Geng E, Mugavero MJ. Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther. 2018 Feb 9. doi: 10.3851/IMP3223.[Epub ahead of print] PMID number: 29424697. PMC number pending.

Bengtson AM, Pence BW, Mollan KR, Edwards JK, Moore RD, OʼCleirigh C, Eaton EF, Eron JJ, Kitahata MM, Mathews WC, Crane H, Mugavero MJ. The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care. J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):402-408. PMID number: 28749824. PMC number: PMC5659970

Buchanan AL, Hudgens MG, Cole SR. Generalizing Evidence from HIV Trials Using Inverse Probability of Sampling Weights. In Quantitative Methods for HIV/AIDS Research, Chan C, Chow SC, Hudgens MG (Eds.). CRC Press, 2018.

Buchanan AL, Hudgens MG, Cole SR, Mollan KR, Sax PE, Daar ES, Adimora AA, Eron JJ, Mugavero MJ. Generalizing evidence from randomized trials using inverse probability of sampling weights. Journal of the Royal Statistical Society: Series A. PMID: 30555215 PMCID: PMC6289264

Chandler R, Gordon MS, Kruszka B, Strand LN, Altice FL, Beckwith CG, Biggs ML, Cunningham W, Chris Delaney JA, Flynn PM, Golin CE, Knight K, Kral AH, Kuo I, Lorvick J, Nance RM, Ouellet LJ, Rich JD, Sacks S, Seal D, Spaulding A, Springer SA, Taxman F, Wohl D, Young JD, Young R, Crane HM. Cohort profile: seek, test, treat and retain United States criminal justice cohort. Substance Abuse Treat Prev Policy. 2017 May 16;12(1):24. PMID number: 28511680. PMC number: PMC5433052

Chung Y, Ivanova A, Hudgens MG, Fine JP. Partial likelihood estimation of isotonic proportional hazards models. Biometrika. 105(1):133–148, 2018.

Chi BH, Rosenberg NE, Mweemba O, Powers KA, Zimba C, Maman S, Kasaro M, Mollan KR, Stringer JS, Mutale W. Involving both parents in HIV prevention during pregnancy and breastfeeding. Bull World Health Organ. 2018 Jan 1;96(1):69-71. Erratum in: Bull World Health Organ. 2018 Mar 1;96(3):220. PMID number: 29403103. PMC number: PMC5791874

Cole SR, Edwards JK, Hall HI, Brookhart MA, Mathews WC, Moore RD, Crane HM, Kitahata MM, Mugavero MJ, Saag MS, Eron JJ; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Investigators. Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States. Clin Infect Dis. 2017 Jun 1;64(11):1591-1596. doi: 10.1093/cid/cix199. PMID: 28498892.

Cole SR, Edwards JK, Westreich D, Lesko CR, Lau B, Mugavero MJ, Mathews WC, Eron JJ Jr, Greenland S; CNICS Investigators. Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model. Biom J. 2018 Jan;60(1):100-114. doi: 10.1002/bimj.201600140. PMID number: 29076182. PMC number: pending

Davis NL, Wiener J, Juliano JJ, Adair L, Chasela CS, Kayira D, Hudgens MG, van der Horst C, Jamieson DJ, Kourtis AP; Breastfeeding, Antiretrovirals and Nutrition (BAN) Study Team. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus-Exposed, Uninfected Infants in Malawi: The BAN Study. Clin Infect Dis. 2017 Aug 15;65(4):575-580. doi: 10.1093/cid/cix367. PMID number: 28444232. PMC number: PMC5850033.

Drozd DR, Saag MS, Westfall AO, Mathews WC, Haubrich R, Boswell SL, Cole SR, Porter D, Kitahata MM, Juday T, Rosenblatt L; CFAR Network of Integrated Clinical Systems (CNICS). Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice. Medicine (Baltimore). 2017 Apr;96(14):e6275. PMID number: 28383402. PMC number: PMC5411186.

Edmonds A, Ludema C, Eron JJ Jr, Cole SR, Adedimeji AA, Cohen MH, Cooper HL, Fischl M, Johnson MO, Krause DD, Merenstein D, Milam J, Wilson TE, Adimora AA. Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV. J Womens Health (Larchmt). 2017 Dec;26(12):1292-1301. PMID number: 28682658. PMC number: PMC5733655.

Edwards JK, Cole SR, Hall HI, Mathews WC, Moore RD, Mugavero MJ, Eron JJ; CNICS investigators. Virologic suppression and CD4+ cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens. AIDS. 2018 Jan 14;32(2):261-266. PMID number: 29112076. PMC number: PMC5736462

Edwards JK, Cole SR, Moore RD, Mathews WC, Kitahata M, Eron JJ. Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula. Am J Epidemiol. 2018 Feb 6. doi: 10.1093/aje/kwy028. [Epub ahead of print] PMID number: 29420696. PMC number: pending.

Eudailey JA, Dennis ML, Parker ME, Phillips BL, Huffman TN, Bay CP, Hudgens MG, Wiseman RW, Pollara JJ, Fouda GG, Ferrari G, Pickup DJ, Kozlowski PA, Van Rompay KKA, De Paris K, Permar SR. Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques. mSphere. 2018 Jan 10;3(1). pii: e00505-17. PMID number: 29359183. PMC number: PMC5760748

Ewing AC, King CC, Wiener JB, Chasela CS, Hudgens MG, Kamwendo D, Tegha G, Hosseinipour MC, Jamieson DJ, Van der Horst C, Kourtis AP. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants. AIDS. 2017 Nov 28;31(18):2455-2463. doi: 10.1097/QAD.0000000000001641. PMID number: 28926409. PMC number: pending.

Fatukasi TV, Cole SR, Moore RD, Mathews WC, Edwards JK, Eron JJ; CNICS investigators. Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients. PLoS One. 2017 Jul 10;12(7):e0180843. PMID number: 28700693. PMC number: PMC5507276.

Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD, Garcia JV. HIV persistence in tissue macrophages of humanized myeloidonly mice during antiretroviral therapy. Nat Med. 2017 May;23(5):638-643. RPPR Page 460. PMID number: 28414330. PMC number: PMC5419854

Howe CJ, Dulin-Keita A, Cole SR, Hogan JW, Lau B, Moore RD, Mathews WC, Crane HM, Drozd DR, Geng E, Boswell SL, Napravnik S, Eron JJ Jr., Mugavero MJ; CFAR Network of Integrated Clinical Systems. Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol. 2018 Feb 1;187(2):316-325. PMID number: 28992096. PMC number: PMC5860258.

Jiang R, Lu W, Song R, Hudgens MG, Naprvavnik S. Doubly robust estimation of optimal treatment regimes for survival data—with application to an HIV/AIDS study. Ann Appl Stat. 2017 Sep;11(3):1763-1786. PMID number: 29308102. PMC number: PMC5749433.

Kessing CF, Nixon CC, Li C, Tsai P, Takata H, Mousseau G, Ho PT, Honeycutt JB, Fallahi M, Trautmann L, Garcia JV, Valente ST. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment. Cell Rep. 2017 Oct 17;21(3):600-611. doi: 10.1016/j.celrep.2017.09.080.  PMID number : 29045830. PMC number: PMC5653276

Lee JS, Cole SR, Richardson DB, Dittmer DP, Miller WC, Moore RD, Kitahata M, Mathews C, Mayer K, Geng E, Achenbach CJ, Eron JJ Jr; Center for AIDS Research Network of Integrated Clinical Systems. Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation. AIDS. 2017 Sep 10;31(14):1989-1997. PMID number: 28650383. PMC number: PMC5695564.

Lesko CR, Buchanan AL, Westreich D, Edwards JK, Hudgens MG, Cole SR. Generalizing Study Results: A Potential Outcomes Perspective. Epidemiology. 2017 Jul;28(4):553-561. PMID number: 28346267. PMC number: PMC5466356.

Lesko CR, Edwards JK, Cole SR, Moore RD, Lau B. When to Censor? Am J Epidemiol. 2018 Mar 1;187(3):623-632. doi: 10.1093/aje/kwx281. PMID number: 29020256. PMC number: pending

Lesko CR, Todd JV, Cole SR, Edmonds A, Pence BW, Edwards JK, Mack WJ, Bacchetti P, Rubtsova A, Gange SJ, Adimora AA; WIHS Investigators. Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formula. Ann Epidemiol. 2017 Dec;27(12):783-789.e2. doi: 10.1016/j.annepidem.2017.08.021. Epub 2017 Sep 5. PMID number: 28939001. PMC number: PMC5714697.

Ludema C, Cole SR, Eron JJ Jr, Holmes GM, Anastos K, Cocohoba J, Cohen MH, Cooper HLF, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA. Health Insurance Type and Control of Hypertension Among US Women Living With and Without HIV Infection in the Women’s Interagency HIV Study. Am J Hypertens. 2017 Jun 1;30(6):594-601. PMID number: 28407044. PMC number: PMC5861569

Menezes P, Mollan K, Hoffman E, Xie Z, Wills J, Marcus C, Rublein J, Hudgens M, Eron JJ. Stable caloric intake and continued virologic suppression for HIV-positive antiretroviral treatment-experienced women after switching to a single-tablet regimen of Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate. AIDS Res Hum Retroviruses. 2018 Apr 1. doi: 10.1089/AID.2016.0311. [Epub ahead of print] PMID number: 29607652. PMC number: PMC5994664.

Mollan KR, Tierney C, Hellwege JN, Eron JJ, Hudgens MG, Gulick RM, Haubrich R, Sax PE, Campbell TB, Daar ES, Robertson KR, Ventura D, Ma Q, Edwards DRV, Haas DW; AIDS Clinical Trials Group. Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants. J Infect Dis. 2017 Sep 1;216(5):554-564. PMID number: 28931220. PMC number: PMC5853681

O’Donnell JK, Gaynes BN, Cole SR, Edmonds A, Thielman NM, Quinlivan EB, Heine A, Modi R, Pence BW. Stressful and traumatic life events as disruptors to antiretroviral therapy adherence. AIDS Care. 2017 Nov;29(11):1378-1385. doi: 10.1080/09540121.2017.1307919. Epub 2017 Mar 28. PMID: 28351158.

Phillips B, Fouda GG, Eudailey J, Pollara J, Curtis AD 2nd, Kunz E, Dennis M, Shen X, Bay C, Hudgens M, Pickup D, Alam SM, Ardeshir A, Kozlowski PA, Van Rompay KKA, Ferrari G, Moody MA, Permar S, De Paris K. Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques. Clin Vaccine Immunol. 2017 Oct 5;24(10). pii: e00231-17. PMID number: 28814388. PMC number: PMC5629672

Price JT, Mollan KR, Fuseini NM, Freeman BL, Mulenga HB, Corbett AH, Vwalika B, Stringer JSA. Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol. Pilot Feasibility Stud. 2017 Jul 18;4:21. Erratum in: Pilot Feasibility Stud. 2017 Oct 24;3:48. PMID number: 28729911. PMC number: PMC5516378

Rudolph JE, Cole SR, Edwards JK, Moore R, O’Cleirigh C, Mathews WC, Christopoulos K; Center for AIDS Research Network of Integrated Clinical Systems. At-Risk Alcohol Use Among HIV-Positive Patients and the Completion of Patient-Reported Outcomes. AIDS Behav. 2018 Apr;22(4):1313-1322. doi: 10.1007/s10461-017-1824-4. PubMed PMID: 28620802. PMC number: PMC5971659 

SESH Study Group, Tucker JD. Crowdsourcing to promote HIV testing among MSM in China: study protocol for a stepped wedge randomized controlled trial. Trials. 2017 Oct 2;18(1):447. doi: 10.1186/s13063-017-2183-1. PMID number: 28969702. PMC number: PMC5625620

Smith JS, Sanusi B, Swarts A, Faesen M, Levin S, Goeieman B, Ramotshela S, Rakhombe N, Williamson AL, Michelow P, Omar T, Hudgens MG, Firnhaber C. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. Am J Obstet Gynecol. 2017 Aug;217(2):183.e1-183.e11. PMID number: 28366730. PMC number pending

Stoner MCD, Cole SR, Price J, Winston J, Stringer JSA. Timing of Initiation of Antiretroviral Therapy and Risk of Preterm Birth in Studies of HIV-infected Pregnant Women: The Role of Selection Bias. Epidemiology. 2018 Mar;29(2):224-229. doi: 10.1097/EDE.0000000000000772. PMID number: 29045283. PMC number: PMC5792303

Stringer JS, Stoner MC, Kasaro MP, Vwalika B, Cole SR. Preconception ART and preterm birth: real effect or selection bias? Lancet HIV. 2017 Apr;4(4):e150. doi: 10.1016/S2352-3018(17)30046-2. PMID number: 28359444. PMC number: pending

Sung JA, Sholtis K, Kirchherr J, Kuruc JD, Gay CL, Nordstrom JL, Bollard CM, Archin NM, Margolis DM. Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells. EBioMedicine. 2017. Sep;23:52-58. PMID number: 28803740. PMC number: PMC5605299

Tang W, Mao J, Tang S, Liu C, Mollan K, Cao B, Wong T, Zhang Y, Hudgens M, Qin Y, Han L, Ma B, Yang B, Ma W, Wei C, Tucker JD; SESH Study Group. Disclosure of sexual orientation to health professionals in China: results from an online cross-sectional study. J Int AIDS Soc. 2017 Feb 6;20(1):21416. doi: 10.7448/IAS.20.1.21416. PMID number: 28361498. PMC number: PMC5467583

Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, Feaster DJ, Gange S, Griswold ME, Mack W, Rubtsova A, Wang C, Weedon J, Anastos K, Adimora AA. Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women. Am J Epidemiol. 2017 May 15;185(10):869-878. PMID number: 28430844. PMC number: PMC5430940

Todd JV, Cole SR, Wohl DA, Simpson RJ Jr, Jonsson Funk M, Brookhart MA, Cocohoba J, Merenstein D, Sharma A, Lazar J, Milam J, Cohen M, Gange S, Lewis TT, Burkholder G, Adimora AA. Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women. AIDS Patient Care STDS. 2017 Nov;31(11):447-454. PMID number: 29087746. PMC number: PMC5665094

Trumble IM, Allmon AG, Archin NM, Rigdon J, Francis O, Baldoni PL, Hudgens MG. SLDAssay: A software package and web tool for analyzing limiting dilution assays. J Immunol Methods. 2017 Nov;450:10-16. PMID number: 28733216. PMC number: PMC5595663

Wang C, Mollan KR, Hudgens MG, Tucker JD, Zheng H, Tang W, Ling L. Generalisability of an online randomised controlled trial: an empirical analysis. J Epidemiol Community Health. 2018 Feb;72(2):173-178. PMID number: 29183956. PMC number: PMC5880638

Willis SJ, Cole SR, Westreich D, Edmonds A, Hurt CB, Albrecht S, Anastos K, Augenbraun M, Fischl M, French AL, Kalapila AG, Karim R, Peters MG, Plankey M, Seaberg EC, Tien PC, Adimora AA. Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy. AIDS. 2018 Mar 13;32(5):653-661. PMID number: 29334550. PMC PMC6024258

Wohl DA, Allmon AG, Evon D, Hurt C, Reifeis SA, Thirumurthy H, Straub B, Edwards A, Mollan KR. Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies. Open Forum Infect Dis. 2017 May 5;4(2):ofx095. doi: 10.1093/ofid/ofx095. eCollection 2017 Spring. PMID number: 28695144. PMC number: PMC5499638

2017

Adimora AA, Cole SR, Eron JJ. US Black Women and Human Immunodeficiency Virus Prevention: Time for New Approaches to Clinical Trials. Clin Infect Dis. 2017 Jul 15;65(2):324-327. PMC5850546.

Bengtson AM, Pence BW, Mollan KR, Edwards JK, Moore RD, OʼCleirigh C, Eaton EF, Eron JJ, Kitahata MM, Mathews WC, Crane H, Mugavero MJ. The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care. J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):402-408. PMC5659970.

Cholera R, Pence BW, Bengtson AM, Crane HM, Christopoulos K, Cole SR, Fredericksen R, Gaynes BN, Heine A, Mathews WC, Mimiaga MJ, Moore R, Napravnik S, O’Clerigh C, Safren S, Mugavero MJ. Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort. PLoS One. 2017 Jan 26;12(1). PMC5268441.

Cole SR, Edwards JK, Westreich D, Lesko CR, Lau B, Mugavero MJ, Mathews WC, Eron JJ Jr, Greenland S; CNICS Investigators. Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model. Biom J. 2017 Oct 27. [Epub ahead of print]. PMC pending. PMID: 29076182

Cole SR, Edwards JK, Hall HI, Brookhart MA, Mathews WC, Moore RD, Crane HM, Kitahata MM, Mugavero MJ, Saag MS, Eron JJ; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Investigators. Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States. Clin Infect Dis. 2017 Jun 1;64(11):1591-1596. PMID: 28498892. PMC pending.

Davis NL, Wiener J, Juliano JJ, Adair L, Chasela CS, Kayira D, Hudgens MG, van der Horst C, Jamieson DJ, Kourtis AP; Breastfeeding, Antiretrovirals and Nutrition (BAN) Study Team; Breastfeeding, Antiretrovirals and Nutrition (BAN) Study Team. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus-Exposed, Uninfected Infants in Malawi: The BAN Study. Clin Infect Dis. 2017 Aug 15;65(4):575-580.  PMID: 28444232. PMC pending.

Dela Peña-Ponce MG, Rodriguez-Nieves J, Bernhardt J, Tuck R, Choudhary N, Mengual M, Mollan KR, Hudgens MG, Peter-Wohl S, De Paris K. Increasing JAK/STAT Signaling Function of Infant CD4(+) T Cells during the First Year of Life. Front Pediatr. 2017 Feb 21;5:15. PMC5318443.

Drozd DR, Saag MS, Westfall AO, Mathews WC, Haubrich R, Boswell SL, Cole SR, Porter D, Kitahata MM, Juday T, Rosenblatt L; CFAR Network of Integrated Clinical Systems (CNICS). Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice. Medicine (Baltimore). 2017 Apr;96(14). PMID 28383402. PMC5411186.

Edmonds A, Ludema C, Eron JJ Jr, Cole SR, Adedimeji AA, Cohen MH, Cooper HL, Fischl M, Johnson MO, Krause DD, Merenstein D, Milam J, Wilson TE, Adimora AA. Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV. J Womens Health (Larchmt). 2017 Jul 6. [Epub ahead of print]. PMID: 28682658. PMC5733655

Ewing AC, King CC, Wiener JB, Chasela CS, Hudgens MG, Kamwendo D, Tegha G, Hosseinipour MC, Jamieson DJ, Van der Horst C, Kourtis AP. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed uninfected infants. AIDS. 2017 Sep 18. [Epub ahead of print]. PMID 28926409. PMC pending.

Fatukasi TV, Cole SR, Moore RD, Mathews WC, Edwards JK, Eron JJ; CNICS investigators. Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients. PLoS One. 2017 Jul 10;12(7). PMID 28700693. PMC5507276.

Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD, Garcia JV. HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy. Nat Med. 2017 May;23(5):638-643. PMID 28414330. PMC5419854.

Howe CJ, Dulin-Keita A, Cole SR, Hogan JW, Lau B, Moore RD, Mathews WC, Crane HM, Drozd DR, Geng E, Boswell SL, Napravnik S, Eron JJ Jr, Mugavero MJ. Evaluating the Population Impact of Intervening on Specific Targets to Reduce HIV Racial/Ethnic Disparities in Adulthood: a Conceptual and Methodological Framework. Am J Epidemiol. 2017 Jul 13. [Epub ahead of print]. PMID 28992096. PMC 5860258.

Jensen K, Dela Pena-Ponce MG, Piatak M Jr, Shoemaker R, Oswald K, Jacobs WR Jr, Fennelly G, Lucero C, Mollan KR, Hudgens MG, Amedee A, Kozlowski PA, Estes JD, Lifson JD, Van Rompay KK, Larsen M, De Paris K. Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine. Clin Vaccine Immunol. 2017 Jan 5;24(1). PMC5216431.

Kessing CF, Nixon CC, Li C, Tsai P, Takata H, Mousseau G, Ho PT, Honeycutt JB, Fallahi M, Trautmann L, Garcia JV, Valente ST. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment. Cell Rep. 2017 Oct 17;21(3):600-611. PMID 29045830. PMC5653276.

Lee JS, Cole SR, Richardson DB, Dittmer DP, Miller WC, Moore RD, Kitahata M, Mathews C, Mayer K, Geng E, Achenbach CJ, Eron JJ Jr; Center for AIDS Research Network of Integrated Clinical Systems. Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation. AIDS. 2017 Sep 10;31(14):1989-1997. PMID 28650383. PMC 5695564.

Lee SK, Zhou S, Baldoni PL, Speilvogel E, Archin NM, Hudgens MG, Margolis DM, Swanstrom R. Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay. J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):221-228. PMC5233602.

Lesko CR, Buchanan AL, Westreich D, Edwards JK, Hudgens MG, Cole SR. Generalizing Study Results: A Potential Outcomes Perspective. Epidemiology. 2017 Jul;28(4):553-561. PMID 28346267. PMC5466356.

Lesko CR, Edwards JK, Cole SR, Moore RD, Lau B. When to Censor? Am J Epidemiol. 2017 Aug 11. [Epub ahead of print]. PMID 29020256. PMC pending.

Lesko CR, Todd JV, Cole SR, Edmonds A, Pence BW, Edwards JK, Mack WJ, Bacchetti P, Rubtsova A, Gange SJ, Adimora AA; WIHS Investigators. Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formula. Ann Epidemiol. 2017 Sep 5. pii: S1047-2797(16)30348-9. [Epub ahead of print]. PMID 28939001. PMC5714697. 

Ludema C, Cole SR, Eron JJ Jr, Holmes GM, Anastos K, Cocohoba J, Cohen MH, Cooper HLF, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA. Health Insurance Type and Control of Hypertension Among US Women Living With and Without HIV Infection in the Women’s Interagency HIV Study. Am J Hypertens. 2017 Jun 1;30(6):594-601. PMID 28407044. PMC5861569.

Mollan KR, Tierney C, Hellwege JN, Eron JJ, Hudgens MG, Gulick RM, Haubrich R, Sax PE, Campbell TB, Daar ES, Robertson KR, Ventura D, Ma Q, Edwards DRV, Haas DW; AIDS Clinical Trials Group. Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants. J Infect Dis. 2017 Sep 1;216(5):554-564. PMID 28931220. PMC 5853681. 

O’Donnell JK, Gaynes BN, Cole SR, Edmonds A, Thielman NM, Quinlivan EB, Heine A, Modi R, Pence BW. Stressful and traumatic life events as disruptors to antiretroviral therapy adherence. AIDS Care. 2017 Nov;29(11):1378-1385. PMID 28351158. PMC pending.

Phillips B, Fouda GG, Eudailey J, Pollara J, Curtis AD 2nd, Kunz E, Dennis M, Shen X, Bay C, Hudgens M, Pickup D, Alam SM, Ardeshir A, Kozlowski PA, Van Rompay KKA, Ferrari G, Moody MA, Permar S, De Paris K. Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques. Clin Vaccine Immunol. 2017 Oct 5;24(10). PMID 28814388. PMC5629672.

Price JT, Mollan KR, Fuseini NM, Freeman BL, Mulenga HB, Corbett AH, Vwalika B, Stringer JSA. Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol. Pilot Feasibility Stud. 2017 Jul 18;4:21. PMID 28729911. PMC5516378.

Qin Y, Tang W, Nowacki A, Mollan K, Reifeis SA, Hudgens MG, Wong NS, Li H, Tucker JD, Wei C. Benefits and Potential Harms of Human Immunodeficiency Virus Self-Testing Among Men Who Have Sex With Men in China: An Implementation Perspective. Sex Transm Dis. 2017 Apr;44(4):233-238. PMC5347468.

Richardson A, Hudgens MG, Fine JP, Brookhart MA. Nonparametric binary instrumental variable analysis of competing risks data. Biostatistics. 2017 Jan;18(1):48-61. PMC pending.

Rudolph JE, Cole SR, Edwards JK, Moore R, O’Cleirigh C, Mathews WC, Christopoulos K; Center for AIDS Research Network of Integrated Clinical Systems. At-Risk Alcohol Use Among HIV-Positive Patients and the Completion of Patient-Reported Outcomes. AIDS Behav. 2017 Jun 15. [Epub ahead of print]. PMID 28620802. PMC pending.

Saag MS, Westfall AO, Cole SR, Mathews WC, Drozd DR, Mayer KH, Burkholder GA, Kitahata M, Maiese EM; CFAR Network of Integrated Clinical Systems (CNICS). Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):60-64. PMC5140679.

SESH Study Group, Tucker JD. Crowdsourcing to promote HIV testing among MSM in China: study protocol for a stepped wedge randomized controlled trial. Trials. 2017 Oct 2;18(1):447. PMID 28969702. PMC5625620.

Smith ER, Hudgens M, Sheahan AD, Miller WC, Wheeler S, Nelson JA, Dube Q, Van Rie A. Timing of HIV Seroreversion Among HIV-Exposed, Breastfed Infants in Malawi: Type of HIV Rapid Test Matters. Matern Child Health J. 2017 Feb;21(2):248-252. PMC5290052.

Smith ER, Sheahan AD, Heyderman RS, Miller WC, Wheeler S, Hudgens M, Nelson JA, Dube Q, Van Rie A. Performance of HIV Rapid Tests Among Breastfeeding, Malawian Infants. Pediatr Infect Dis J. 2017 Apr;36(4):405-411. PMC pending.

Smith JS, Sanusi B, Swarts A, Faesen M, Levin S, Goeieman B, Ramotshela S, Rakhombe N, Williamson AL, Michelow P, Omar T, Hudgens MG, Firnhaber C. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. Am J Obstet Gynecol. 2017 Aug;217(2):183.  PMID 28366730. PMC pending.

Stoner MCD, Cole SR, Price J, Winston J, Stringer JSA. Timing of initiation of antiretroviral therapy and risk of preterm birth in studies of HIV-infected pregnant women: the role of selection bias. Epidemiology. 2017 Oct 16. [Epub ahead of print]. PMID 29045283. PMC pending.

Stringer JS, Stoner MC, Kasaro MP, Vwalika B, Cole SR. Preconception ART and preterm birth: real effect or selection bias? Lancet HIV. 2017 Apr;4(4). PMID 28359444. PMC pending.

Tang W, Mao J, Tang S, Liu C, Mollan K, Cao B, Wong T, Zhang Y, Hudgens M, Qin Y, Han L, Ma B, Yang B, Ma W, Wei C, Tucker JD; SESH Study Group. Disclosure of sexual orientation to health professionals in China: results from an online cross-sectional study. J Int AIDS Soc. 2017 Feb 6;20(1):21416. PMID 28361498. PMC5467583.

Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, Feaster DJ, Gange S, Griswold ME, Mack W, Rubtsova A, Wang C, Weedon J, Anastos K, Adimora AA. Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women. Am J Epidemiol. 2017 May 15;185(10):869-878. PMID 28430844. PMC5430940.

Trumble IM, Allmon AG, Archin NM, Rigdon J, Francis O, Baldoni PL, Hudgens MG. SLDAssay: A software package and web tool for analyzing limiting dilution assays. J Immunol Methods. 2017 Nov;450:10-16. PMID 28733216. PMC5595663.

Wahl A, Ho PT, Denton PW, Garrett KL, Hudgens MG, Swartz G, O’Neill C, Veronese F, Kashuba AD, Garcia JV. Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model. Sci Rep. 2017 Feb 1;7:41098. PMC5286499.

Wohl DA, Allmon AG, Evon D, Hurt C, Reifeis SA, Thirumurthy H, Straub B, Edwards A, Mollan KR. Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies. Open Forum Infect Dis. 2017 May 5;4(2). PMID 28695144. PMC5499638.

Wohl DA, Panter AT, Kirby C, Magnus BE, Hudgens MG, Allmon AG, Mollan KR. Estimating HIV Medication Adherence and Persistence: Two Instruments for Clinical and Research Use. AIDS Behav. 2017 Apr 26. [Epub ahead of print]. PMC pending.

Wohl DA, Golin CE, Knight K, Gould M, Carda-Auten J, Groves JS, Napravnik S, Cole SR, White BL, Fogel C, Rosen DL, Mugavaro MJ, Pence BW, Flynn PM. A Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia Following Prison Release: The imPACT Trial. J Acquir Immune Defic Syndr. 2017 Mar 8. [Epub ahead of print]. PMC pending.

Zadrozny S, Westreich D, Hudgens MG, Chasela C, Jamieson DJ, Martinson F, Zimba C, Tegha G, Hoffman I, Miller WC, Pence BW, King CC, Kourtis AP, Msungama W, van der Horst C; BAN Study Team. Effect of Postnatal HIV Treatment on Clinical Mastitis and Breast Inflammation in HIV-Infected Breast-feeding Women. Paediatr Perinat Epidemiol. 2017 Feb 16. [Epub ahead of print]. PMC pending.

2016

Chibwesha CJ, Ford CE, Mollan KR, Stringer JS. Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children in Zambia: A Clinical Trial Protocol. J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S197-201. PMC5113248.

Clutton G, Xu Y, Baldoni PL, Mollan KR, Kirchherr J, Newhard W, Cox K, Kuruc JD, Kashuba A, Barnard R, Archin N, Gay CL, Hudgens MG, Margolis DM, Goonetilleke N. The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function. Sci Rep. 2016 Aug 2;6:30749. PMC4969750.

Cottrell ML, Prince HM, Allmon A, Mollan KR, Hudgens MG, Sykes C, White N, Malone S, Dellon ES, Madanick RD, Shaheen NJ, Patterson KB, Kashuba AD. Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial Design. J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):498-506. PMC4942408

Cottrell ML, Yang KH, Prince HM, Sykes C, White N, Malone S, Dellon ES, Madanick RD, Shaheen NJ, Hudgens MG, Wulff J, Patterson KB, Nelson JA, Kashuba AD. A Translational Pharmacology Approach to Predicting HIV Pre-Exposure Prophylaxis Outcomes in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine. J Infect Dis. 2016 Jul 1;214(1):55-64. PMC4907409

Davis NL, Miller WC, Hudgens MG, Chasela CS, Sichali D, Kayira D, Nelson JA, Fiscus SA, Regha G, Kamwendo DD, Rigdon J, Stringer JS, Juliano JJ, Ellington SR, Kourtis AP, Jamieson DJ, van der Horst C, BAN study team. Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted – The Breastfeeding, Antiretrovirals, and Nutrition Study. J Acquir Immune Defic Syndr. 2016 Dec 15; 73 (5): 572-580. PMC5141681.

Dumond JB, Francis O, Cottrell M, Trezza C, Prince HM, Mollan K, Sykes C, Torrice C, White N, Malone S, Wang R, Van Dam C, Patterson KB, Hudgens MG, Sharpless NE, Forrest A. Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapy. Antivir Ther. 2016;21(5):441-5. PMC5266614.

Edwards JK, Cole SR, Lesko CR, Mathews WC, Moore RD, Mugavero MJ, Westreich D. An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects. Am J Epidemiol. 2016 Aug 15;184(4):336-44. PMC4983650.

Floris-Moore MA, Mollan K, Wilkin AM, Johnson MA, Kashuba ADM, Wohl DA, Patterson KB, Francis O, Kronk C, Eron JJ. Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results. Antivir Ther. 2016;21(1):55-64.

Howe CJ, Cole SR, Lau B, Napravnik S, Eron JJ Jr. Selection Bias Due to Loss to Follow Up in Cohort Studies. Epidemiology. 2016 Jan;27(1):91-7. PMC5008911.

Hudgens MG. Rejoinder to “Reader reaction: A note on the evaluation of group testing algorithms in the presence of misclassification”. Biometrics. 2016 Mar;72(1):304.

Jensen K, Nabi R, Van Rompay KK, Robichaux S, Lifson JD, Piatak M Jr, Jacobs WR Jr, Fennelly G, Canfield D, Mollan KR, Hudgens MG, Larsen MH, Amedee AM, Kozlowski PA, De Paris K. Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques. J Virol. 2016 Jul 27;90(16):7285-302. PMC4984660.

Lee H, Hudgens MG, Cai J, Cole SR. Marginal Structural Cox Models with Case Cohort Sampling. Stat Sin. 2016 Apr;26(2):509-526. PMC4820319.

Lesko CR, Cole SR, Hall HI, Westreich D, Miller WC, Eron JJ, Li J, Mugavero MJ; CNICS Investigators. The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11. Int J Epidemiol. 2016 Feb;45(1):140-50. PMC5013889.

Liu C, Mao J, Wong T, Tang W, Tso LS, Tang S, Zhang Y, Zhang W, Qin Y, Chen Z, Ma W, Kang D, Li H, Liao M, Mollan K, Hudgens M, Bayus B, Huang S, Yang B, Wei C, Tucker JD. Comparing the effectiveness of a crowdsourced video and a socialmarketing video in promoting condom use among Chinese men who have sex with men: a study protocol. BMJ Open. 2016 Oct 3;6(10). PMC5073617.

Lodi S, Sharma S, Lundgren JD, Phillips AN, Cole SR, Logan R, Agan BK, Babiker A, Klinker H, Chu H, Law M, Neaton JD, Hernán MA; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) study group. The per-protocol effect of immediate versus deferred antiretroviral therapy initiation. AIDS. 2016 Nov 13;30(17):2659-2663. PMC5339063.

Ludema C, Cole SR, Eron JJ Jr, Edmonds A, Holmes GM, Anastos K, Cocohoba J, Cohen M, Cooper HL, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA. Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women’s Interagency HIV Study, 2006-2009. JAcquir Immune Defic Syndr. 2016 Nov 1;73(3):307-312. PMC5089078.

Maas BM, Francis O, Mollan KR, Lee C, Cottrell ML, Prince HM, Sykes C, Trezza C, Torrice C, White N, Malone S, Hudgens MG, Sharpless NE, Dumond JB. Concentrations of pro-inflammatory cytokines are not associated with senescence marker p16INK4a or predictive of intracellular emtricitabine/tenofovir metabolite and endogenous nucelotide exposures in adults with HIV infection. PLoS One. 2016 Dec 30; 11 (12). PMC5201235.

Nelson CS, Pollara J, Kunz EL, Jeffries TL Jr, Duffy R, Beck C, Stamper L, Wang M, Shen X, Pickup DJ, Staats HF, Hudgens MG, Kepler TB, Montefiori DC, Moody MA, Tomaras GD, Liao HX, Haynes BF, Ferrari G, Fouda GG, Permar SR. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk. J Virol. 2016 Apr 29;90(10):4951-65. PMC4859715

O’Donnell JK, Gaynes BN, Cole SR, Edmonds A, Thielman NM, Quinlivan EB, Shirey K, Heine AD, Modi R, Pence BW. Ongoing life stressors and suicidal ideation among HIV-infected adults with depression. J Affect Disord. 2016 Jan 15;190:322-8. PMC4685465

Olesen R, Swanson MD, Kovarova M, Nochi T, Chateau M, Honeycutt JB, Long JM, Denton PW, Hudgens MG, Richardson A, Tolstrup M, Østergaard L, Wahl A, Garcia JV. ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions. J Clin Invest. 2016 Mar 1;126(3):892-904. PMC4767352

Rosen DL, Wohl DA, Golin CE, Rigdon J, May J, White BL, Leone PA, Hudgens MG, Bowling JM. Comparing HIV case detection in prison during opt-in vs. opt-out testing policies. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):e85-8. PMC4752376

Senkomago V, Backes DM, Hudgens MG, Poole C, Meshnick SR, Agot K, Moses S, Snijders PJ, Meijer CJ, Hesselink AT, Schlecht NF, Bailey RC, Smith JS. Higher HPV16 and HPV18 Penile Viral Loads Are Associated With Decreased Human Papillomavirus Clearance in Uncircumcised Kenyan Men. Sex Transm Dis. 2016 Sep;43(9):572-8. PMC4985051.

Shepherd BE, Liu Q, Mercaldo N, Jenkins CA, Lau B, Cole SR, Saag MS, Sterling TR. Comparing results from multiple imputation and dynamic marginal structural models for estimating when to start antiretroviral therapy. Stat Med. 2016 Oct 30;35(24):4335-4351. PMC5048599.

Tang W, Han L, Best J, Zhang Y, Mollan K, Kim J, Liu F, Hudgens M, Bayus B, Terris-Prestholt F, Galler S, Yang L, Peeling R, Volberding P, Ma B, Xu H, Yang B, Huang S, Fenton K, Wei C, Tucker JD. Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China. Clin Infect Dis. 2016 Jun 1;62(11):1436-42. PMC4872295

Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, Moore RD, Mathews WC, Drozd DR, Hamdan A, Ballestas ME, Engels EA. Changes in Clinical Context for Kaposi’s Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States. J Clin Oncol. 2016 Sep 20;34(27):3276-83.

2015

Cole SR, Hudgens MG, Brookhart MA, Westreich D. Risk. Am J Epidemiol. 2015 Feb 15;181(4):246-50. PMC4325680

Cole SR, Lau B, Eron JJ, Brookhart MA, Kitahata MM, Martin JN, Mathews WC, Mugavero MJ; for the CNICS Research Network. Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework: Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy. Am J Epidemiol. 2015 Feb 15;181(4):238-45. PMC4325676

Davis NL, Barnett EJ, Miller WC, Dow A, Chasela CS, Hudgens MG, Kayira D, Tegha G, Ellington SR, Kourtis AP, van der Horst C, Jamieson DJ, Juliano JJ. Impact of Daily Cotrimoxazole on Clinical Malaria and Asymptomatic Parasitemias in HIV-Exposed, Uninfected Infants. Clin Infect Dis. 2015 Aug 1;61(3):368-74. PMC4542924

Dumond JB, Rigdon J, Collier AC, Mollan K, Tierney C, Aweeka F, Kashuba ADM. Significant Decreases in both Total and Unbound Lopinavir and Amprenavir Exposures during Co-Administration: ACTG Protocol A5143/A5147s Results. J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):510-4. PMC4648657

Edwards JK, Cole SR, Adimora A, Fine J, Martin J, Eron J. Illustration of a measure to combine viral suppression and viral rebound in studies of HIV therapy. J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):241-4. PMC4294958

Edwards JK, Cole SR, Westreich D, Crane H, Eron JJ, Mathews WC, Moore R, Boswell SL, Mugavero MJ. Multiple Imputation to Account for Measurement Error in Marginal Structural Models. Epidemiology 2015 Sep;26(5):645-52. PMC4638124

Edwards JK, Cole SR, Martin JN, Moore R, Mathews WC, Kitahata M, Eron JJ, Saag M, Mugavero MJ, CNICS Investigators. Dynamic Visual Display of Treatment Response in HIV-Infected Adults. Clin Infect Dis 61:e1-4. 2015. PMC4481601.

Edwards JK, Cole SR, Westreich D, Mugavero MJ, Eron JJ, Moore RD, Mathews WC, Hunt P, Williams C, CNICS investigators. Age at Entry into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality among HIV-Seropositive Adults in the United States. Clin Infect Dis 2015 Oct 1;61(7):1189-95. PMC4560906.

Feinstein L, Edmonds A, Okitolonda V, Cole SR, Van Rie A, Chi BH, Ndjibu P, Lusiama J, Chalachala JL, Behets F. Maternal Combination Antiretroviral Therapy is Associated with Improved Retention of HIV-Exposed Infants in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr 2015 Jul 1;69(3):e93-9. PMC4506694.

Firnhaber C, Mao L, Levin S, Faesen M, Lewis DA, Goeieman BJ, Swarts AJ, Rakhombe N, Michelow PM, Williams S, Smith JS. Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa. J Low Genit Tract Dis. 2015 Jan;19(1):7-11. PMC4272220

Flax VL, Adair LS, Allen LH, Shahab-Ferdows S, Hampel D, Chasela CS, Tegha G, Daza EJ, Corbett A, Davis NL, Kamwendo D, Kourtis AP, van der Horst CM, Jamieson DJ, Bentley ME; BAN Study Team. Plasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women. J Nutr. 2015 Aug;145(8):1950-7. PMC4516772

Geng Y, Zhang HH, Lu W. On Optimal Treatment Regimes Selection for Mean Survival Time. Stat Med. 2015 Mar 30;34(7):1169-84. PMC4355217

Herce ME, Kalanga N, Wroe EB, Keck JW, Chingoli F, Tengatenga L, Gopal S, Phiri A, Mailosi B, Bazile J, Beste JA, Elmore SN, Crocker JT, Rigodon J. Excellent Clinical Outcomes and Retention in Care for Adults with HIV-Associated Kaposi Sarcoma Treated with Systemic Chemotherapy and Integrated Antiretroviral Therapy in Rural Malawi. J Int AIDS Soc 18:19929. 2015. PMC4450240.

King CC, Kourtis AP, Persaud D, Nelson JAE, Ziemniak C, Hudgens MG, Tegha G, Chasela CS, Jamieson DJ, van der Horst CM. Delayed HIV Detection among Infants Exposed to Postnatal ARV Prophylaxis during Breastfeeding. AIDS 2015 Sep 24;29(15):1953-61. PMC4665628

Lesko CR, Cole SR, Miller WC, Westreich D, Eron JJ, Adimora AA, Moore RD, Mathews WC, Martin JN, Drozd DR, Kitahata MM, Edwards JK, Mugavero MJ. Ten-year survival by race/ethnicity and sex among treated, HIV-infected adults in the United States. Clin Infect Dis. 2015 Jun 1;60(11):1700-7. PMC4447784

Long DM, Hudgens MG, Wu CD. Surrogates of protection in repeated low-dose challenge experiments. Stat Med. 2015 May 10;34(10):1747-60. PMC4390486

Nelson JAE, Fokar A, Hudgens MG, Compliment KJ, Hawkins JT, Tegha G, Kamwendo DD, Kayira D, Mofolo IA, Kourtis AP, Jamieson DJ, van der Horst CM, Fiscus SA. Frequent Nevirapine Resistance in Infants Infected by HIV-1 Via Breastfeeding while on Nevirapine Prophylaxis: Results of the BAN Study. AIDS. 2015 Oct 23;29(16):2131-8. PMC4715989

Nevo ON, Lesko C, Colwell B, Ballard C, Cole SR, Mathews WC. Outcomes of Pharmacist Assisted Management of Antiretroviral Therapy in HIV Infected Patients: A Risk-Adjusted Analysis. American Journal of Health-Systems Pharmacy 2015 Sep 1;72(17):1463-70. PMC4877692

Nolen TL, Hudgens MG, Senb PK, Koch GG. Analysis of repeated low-dose challenge studies. Stat Med. 2015 May 30;34(12):1981-92. PMC4420691

Onsomu EO, Abuya BA, Okech IN, Rosen DL, Duren-Winfield V, Simmons AC. Association between domestic violence and HIV serostatus among married and formerly married women in kenya. Health Care Women Int. 2015 Feb; 36(2): 205-228. PMC4312516.

Oxford KL, Dela Pena-Ponce MG, Jensen K, Eberhardt MK, Spinner A, Van Rompay KK, Rigdon J, Mollan KR, Krishnan VV, Hudgens MG, Barry PA, De Paris K. The interplay between immune maturation, age, chronic viral infection and environment. Immun Ageing. 2015 May 9;12:3. PMC4436863

Richardson DB, Kinlaw AC, MacLehose RF, Cole SR. Standardized binomial models for risk or prevalence ratios and differences. Int J Epidemiol. 2015 Oct;44(5):1660-72. PMC Pending.

Sellers CJ, Lee H, Chasela C, Kayira D, Soko A, Mofolo I, Ellington S, Hudgens MG, Kourtis AP, King CC, Jamieson DJ, van der Horst C; BAN Study Team. Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: The Breastfeeding, Antiretrovirals and Nutrition study experience. Clin Trials. 2015 Apr;12(2):156-65. PMC4355163

Senkomago V, Backes DM, Hudgens MG, Poole C, Agot K, Moses S, Snijders PJ, Meijer CJ, Hesselink AT, Schlecht NF, Bailey RC, Smith JS. Acquisition and persistence of human papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, Kenya. J Infect Dis. 2015 Mar 1;211(5):811-20. PMC4402376

Soriano-Sarabia N, Archin NM, Bateson R, Dahl NP, Crooks AM, Kuruc JD, Garrido C, Margolis DM. Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection. PLoS Pathog. 2015 Oct 16;11(10):e1005201. PMC4608739

Sung JA, Lam S, Garrido C, Archin N, Rooney CM, Bollard CM, Margolis DM. Expanded Cytotoxic T-Cell Lymphocytes Target the Latent HIV Reservoir. J Infect Dis 212:258-263. 2015. PMC4490234.

Tashima KT, Mollan KR, Na L, Gandhi RT, Klingman KL, Fichtenbaum CJ, Andrade A, Johnson VA, Eron JJ, Smeaton L, Haubrich RH. Regimen Selection in the OPTIONS Trial of HIV Salvage Therapy: Drug Resistance, Prior Therapy, and Race-Ethnicity Determine the Degree of Regimen Complexity HIV Clinical Trials. HIV Clinical Trials 2015 Aug;16(4):147-56. PMC4640927.

Vardhanabhuti S, Taiwo B, Kuritzkes DR, Eron JJ,Jr, Bosch RJ. Phylogenetic Evidence of HIV-1 Sequence Evolution in Subjects with Persistent Low-Level Viraemia. Antivir Ther 20:73-76. 2015. PMC4185268.

Vielot N, Hudgens MG, Mugo N, Chitwa M, Kimani J, Smith J. The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya. Sex Transm Dis. 2015 Jun;42(6):305-11.PMC4435827

White BL, Golin CE, Grodensky CA, Kiziah CN, Richardson A, Hudgens MG, Wohl DA, Kaplan AH. Effect of Directly Observed Antiretroviral Therapy Compared to Self-Administered Antiretroviral Therapy on Adherence and Virological Outcomes among HIV-Infected Prisoners: A Randomized Controlled Pilot Study. AIDS Behav. 2015 Jan;19(1):128-36. PMC4303492

Willoughby JF. BrdsNBz: Sexually Experienced Teens More Likely to use Sexual Health Text Message Service. Health Educ Behav 2015 Apr 17. 2015. PMC pending.

Zhou S, Jones C, Mieczkowski P, Swanstrom R. Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next Generation Sequencing of HIV-1 Genomic RNA Populations. J Virol 2015 Aug;89(16):8540-55. PMC4524263.

Trainings

Power and Sample Size Boot Camp

An Overview of Biostatistics

Biostatistics Core Research Group

Tools

R package for Serial Limiting Dilution Assay Statistics (SLDAssay)

Power Calculator for Repeated Low-Dose Challenge Studies

R Package for Rank-Sum Power Calculation (wmwpow)

 

Brief Statistical Safety Checklist

Statistical Checklist

Purpose:

This checklist is designed to help review draft manuscripts, statistical reports, or analysis plans

Methods:

-Objective / hypotheses of the study are clearly stated

-Endpoints are defined, declare endpoints as primary, secondary, and exploratory as appropriate

-Exposures and covariates are defined

-Sample size calculation is explained (if applicable)

-If applicable, randomization and blinding process are explained

-If applicable, interim stopping guidelines are described

-All statistical methods are described (with references as needed)

-Methodological assumptions were reasonably met

-Reasonable considerations were made for:

-missing data or attrition (e.g. loss to follow-up)

-multiple testing or multiple comparisons

-correlation among observations (e.g. longitudinal or clustered data)

-small sample sizes (e.g. n<30)

-Statistical software and version used are stated (e.g. SAS version 9.3, Cary, North Carolina)

-Statistical significance level is declared (e.g. two-sided .05 significance level)

-Clinical trials: trial registration # included (www.clinicaltrials.gov)

Results (including text, tables, figures):

-“Avoid nontechnical uses of technical terms in statistics, such as random (which implies a randomizing device), normal, significant, correlations, and sample.” 1

-Number of decimal places reported appropriately reflects measurement precision

-Summaries of variability/spread are provided (e.g. SD, IQR)

-Sample sizes are provided (n=) and missing data are declared when applicable

-Each p-value is accompanied by a graphical display of data, descriptive statistics, or a confidence interval

-Specific p-values are reported, rather than p<0.05

-“Use of the word significant should always be accompanied by a p-value; otherwise, use substantial, considerable, etc.”3

-Figures are clearly explained by a legend and all axes and symbols are appropriately labeled

-“Any distorted effect sizes (e.g. by truncation of y axis) are clearly labeled and justified”3

-Units of measurement are stated

Discussion:

-Discussion conclusions are in agreement with results

-Limitations of the study design or analytic approach are appropriated stated

For more guidance, refer to standard reporting guidelines (e.g. CONSORT, STROBE, PRISMA, STARD)

References:

  1. http://jama.jamanetwork.com/public/instructionsForAuthors.aspx
  2. http://annals.org/SS/AuthorInformationStatisticsOnly.aspx
  3. http://www.nature.com/srep/authors/submit.html#statistical-guidelines
  4. http://stm.sciencemag.org/site/misc/auth_inst_ra.xhtml#5
“To consult the statistician after an experiment is finished is often merely to ask them to conduct a post mortem examination. They can perhaps say what the experiment died of.” R.A. Fisher